Skip to content
The Biotechnology Innovation Organization (BIO) recently told the U.S. Patent and Trademark Office (USPTO) that proposed changes to the pharmaceutical patent process are flawed—and […]
BIO says that proposed changes to pharma patents would harm innovation Read More »
Partisan divisions were on display at a joint hearing of the House Energy & Commerce Committee’s Health and Oversight & Investigations subcommittees, as Republicans
Administration officials return to Congress to discuss COVID-19 response Read More »
In his State of the Union speech last night, President Joe Biden hailed the end of the COVID-19 emergency while ignoring the contribution of
State of the Union: Biden’s remarks on drug price controls and biomedical innovation Read More »
The Inflation Reduction Act’s drug price controls have been a hot topic during the BIO CEO and Investor Conference—and one that has hampered an
We’re already seeing the impact of drug price controls, say biotech CEOs Read More »
With the 118th Congress picking up steam, the Biotechnology Innovation Organization’s (BIO) Federal Government Relations team shared what to expect in health care and
What BIO’s watching on health care and agriculture policy in 2023 Read More »
In a move that will help the 340B pharmaceutical discount program get back on track, the U.S. Third Circuit Court of Appeals decided Monday
Federal court rules against HHS on 340B contract pharmacies Read More »
Yesterday, the Biotechnology Innovation Organization’s (BIO) Clinical Trial Diversity Roundtable brought together leaders from government, industry, and patient groups to begin implementing the clinical
BIO roundtable works toward greater clinical trial diversity Read More »
A significant date for biotechnology and the historic fight to create vaccines, the Biden administration will end the COVID-19 public health emergency on May
U.S. COVID public health emergency will end in May Read More »
A whole new strain of Porcine Reproductive and Respiratory Syndrome (PRRS) has spread to six U.S. states, reports Pig Progress—highlighting the importance of advancing
Deadly pig disease variant stresses the need for animal biotech Read More »
To simplify and streamline the COVID-19 vaccination process while pushing for increased vaccination rates, the U.S. Food and Drug Administration (FDA) proposed updating the
FDA proposes updating COVID boosters annually Read More »
